AI assistant
QuantumScape Corp — Director's Dealing 2021
Aug 4, 2021
30821_dirs_2021-08-04_28538608-8db8-4cfb-bed1-913d43305962.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: QuantumScape Corp (QS)
CIK: 0001811414
Period of Report: 2021-08-02
Reporting Person: Leohold Jurgen (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-08-02 | Class A Common Stock | M | 50000 | $1.3252 | Acquired | 147295 | Direct |
| 2021-08-02 | Class A Common Stock | S | 39831 | $22.4125 | Disposed | 107464 | Direct |
| 2021-08-02 | Class A Common Stock | S | 10169 | $23.3088 | Disposed | 97295 | Direct |
| 2021-08-03 | Class A Common Stock | M | 100000 | $2.377 | Acquired | 197295 | Direct |
| 2021-08-03 | Class A Common Stock | S | 34181 | $21.6983 | Disposed | 163114 | Direct |
| 2021-08-03 | Class A Common Stock | S | 15619 | $22.4355 | Disposed | 147495 | Direct |
| 2021-08-03 | Class A Common Stock | S | 200 | $23.035 | Disposed | 147295 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-08-02 | Stock Option (right to buy) | $1.3252 | M | 50000 | Disposed | 2027-12-13 | Class A Common Stock (50000) | Direct |
| 2021-08-03 | Stock Option (right to buy) | $2.377 | M | 100000 | Disposed | 2029-12-11 | Class A Common Stock (100000) | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.00 to $22.985, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.02 to $23.70, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.54 to $21.87, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.00 to $22.87, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.07, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
F6: 20% of the shares subject to the option vested and became exercisable on January 1, 2019, and the remaining shares will vest monthly thereafter, subject to the Reporting Person's continued service at each vesting date.
F7: 20% of the shares subject to the option will vest and become exercisable on December 11, 2020, and the remaining shares will vest monthly thereafter, subject to the Reporting Person's continued service at each vesting date.